Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Tracking error arises from fees, sampling, and/index composition differences. This intro covers primary causes and practical mitigation ideas.
19,096 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
An emerging critical iPhone exploit targets crypto apps as Morgan Stanley moves to shore up Bitcoin infrastructure wi...
Nvidia's GTC keynote spotlighted agentic AI and robotics, laying out a future where startups must adapt to new comput...
A security flaw allowed a hacker to drain approximately $5.9 million from TrustedVolumes, a DeFi liquidity provider o...
Frontline loan teams report AI fatigue but are finding practical paths forward. This article outlines simple, actiona...
Ad-tech leaders Trade Desk and AppLovin face renewed scrutiny in 2026 as AI investments pressure margins and trigger ...
CNBS traders are weighing a high-conviction cannabis theme against a thin dividend base. The ETF leans on one rent-pr...
A tiny 0.06% fee on SCHD masks a much larger cost: a 38% decade-long performance gap versus peers, with outsized oppo...
Jamie Dimon drops a bold note on AI’s real impact at JPMorgan: it’s already trimming headcount in some units, but pro...
A financially secure couple with a three million dollar nest egg wonders if their plan can support an early retiremen...
Regulatory tightening is reshaping crypto’s path. Barabash argues the most regulated platforms may become the biggest...
Federal Reserve Chair Jerome Powell acknowledges that AI-driven data-center expansion is lifting consumer costs in th...